CD274 and neoplasm: It should be emphasized that, in addition to PD-L1 expression, other biomarkers, such as tumor mutational burden (TMB), Epstein–Barr virus-encoded RNA (EBER) status, and microsatellite instability (MSI) status, might have the potential to predict the response to ICIs.